Navigation Links
R3 Stem Cell Effectively Incorporates Artificial Intelligence Into Client Marketing
Date:12/18/2018

The nation’s leader in stem cell marketing, R3 Stem Cell, has effectively incorporated artificial intelligence into client marketing. The technology has been effective at reducing patient acquisition costs by over thirty percent.

For over six years, R3 Stem Cell has been working with clients nationwide on patient acquisition marketing programs. Traditional marketing for stem cell patients involves a considerable spend with a very low yield. R3 Stem Cell uses state of the art methods to reach a more targeted audience that has a much higher yield than the traditional methods.

One of the most exciting methods R3 uses has been artificial intelligence. This involves analyzing live phone calls with a machine to understand how the best leads correlate with certain keywords, times of day, geography and how the calls are handled at the practice.

It is well known that most clients have no method of handling the ridiculous amounts of data available to them and make useful decisions. So most practices simply use traditional marketing methods which are expensive and low yield.

Said R3 Stem Cell Marketing CEO Dr. David Greene, “While artificial intelligence is complicated, we have developed a proprietary system that uses available data to figure out what is working best so we can deploy resources better and more cost effectively. This helps clients big time!”

Every month, R3’s marketing team generates thousands of prospective patient leads nationwide. The AI methods have dramatically assisted in the effort, along with the sales training that is taught in conjunction.

For a complimentary stem cell marketing consultation, visit http://stemcellmarketing.com or call (844) GET-STEM.

Read the full story at https://www.prweb.com/releases/r3_stem_cell_effectively_incorporates_artificial_intelligence_into_client_marketing/prweb15992333.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. New class of anti-arthritis drugs effectively treats multiple inflammatory diseases
2. Stem cell mobilization therapy may effectively treat osteoarthritis
3. Automated CT dose-tracking software effectively monitors dosage in a clinical setting
4. Ordinary conditioner removes head lice eggs as effectively as special products
5. Study finds Catalina Island Conservancy contraception program effectively manages bison population
6. New substance effectively combats multi-resistant bacteria
7. Largest therapy trial worldwide: Psychotherapy treats anorexia effectively
8. Immunohistochemistry effectively detects ALK rearrangement
9. Zipongo Incorporates 23andMe Reports Into Personalized Nutrition Plans
10. New Research: Artificial Intelligence Non-Invasively Detects Chromosome 21-Linked Genetic Disorders
11. Mintigo Delivers Artificial Intelligence For Salesforce CRM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2019)... ... , ... Clean label food is not just another passing trend in the ... is quite common to spot consumers running their index finger across the back of ... label scrutiny. , More than ever, meat and poultry producers are working diligently ...
(Date:2/22/2019)... ... February 21, 2019 , ... On January 7th, ... SacroFuse system in conjunction with NanoFUSE’s Orthobiologic during a surgery at ... time that either SacroFuse or NanoFUSE have been used in Latin America. ...
(Date:2/19/2019)... ... February 20, 2019 , ... ... that will see Dimensions rolled out across the organization. Dimensions provides in-depth ... across their business, support strategic planning, and understand past and future funding ...
Breaking Biology News(10 mins):
(Date:3/15/2019)... SÃO PAULO and ATLANTA (PRWEB) , ... ... ... GranBio completed the acquisition of 100% equity in American Process Inc. and ... assets include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and ...
(Date:3/14/2019)... ... March 14, 2019 , ... ON NOVEMBER 27, 2018, ... the Eye Machine Canada Inc., had been given approval to begin a clinical ... Macular Degeneration (AMD). , The previous month, the medical devices bureau of Health ...
(Date:3/12/2019)... ... 2019 , ... Centura Health, the region’s health care leader, ... the nation, to offer needle-free blood draws for inpatients. , Littleton Adventist Hospital ... staff showed compassion jumped up by an average of 15.4% during the 90 ...
(Date:3/9/2019)... ... March 07, 2019 , ... ACEA Biosciences Inc. ... and commercialization of high performance, cutting-edge cell analysis platforms for life science research. ... expertise in cardiovascular pharmacology and electrophysiology, are announcing a partnership to provide comprehensive ...
Breaking Biology Technology: